Delivery Order SPE2DB22D1106-SPE2DB24FFKU7

Award Date 9/4/24
Potential Completion Date 9/5/24
Potential Value $9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to AmerisourceBergen Drug Corp for the supply of ENBREL 50 MG/ML SYRINGEML. The $20,067.68 Firm Fixed Price contract has a completion date of December 9, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
The U.S. government awarded a Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ENBREL 50 MG/ML SYRINGEML. The $9,158.68 contract is funded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of May 23, 2025. The contract is not set aside and represents an open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the DLA Troop...
The U.S. Defense Logistics Agency (DLA) awarded a $9,897.94 firm-fixed-price delivery order to AmerisourceBergen Drug Corporation's Corporate Office division for the supply of ENBREL 50 MG/ML SURECLICKML pharmaceutical product. This delivery order falls under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with DLA Troop Support Medical for the provision of a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The...
The U.S. Defense Logistics Agency (DLA) awarded a $4,152.14 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide ENBREL 50 MG/ML syringes. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp by DLA Troop Support Medical, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ENBREL 50 MG/ML syringes. The contract has a potential value of $9,301.30 and a performance period through March 5, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary...
The U.S. Defense Logistics Agency (DLA) awarded a $51,462.68 firm fixed-price delivery order to AmerisourceBergen Drug Corporation for the supply of ENBREL 50 MG/ML SURECLICK syringes. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The contract has a completion date...
<p>The Defense Logistics Agency (DLA) awarded a $55,994.41 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp for the delivery of 4563106804 ENBREL 50 MG/ML SYRINGEML. This order is part of AmerisourceBergen's existing $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides pharmaceutical products and medical supplies to support military healthcare programs globally. No set-aside designation was used for this contract award.</p>
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract (SPE2DB22D3011) to AmerisourceBergen Drug Corp, a subsidiary of the pharmaceutical distribution company AmerisourceBergen Corporation. The $9,399.79 contract is for the supply of ENBREL 50 MG/ML syringes, with an ultimate completion date of April 4, 2024. This delivery order falls under a larger indefinite delivery contract (SPE2DB24FQ0JE) awarded solely to AmerisourceBergen Drug Corp, which has a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ENBREL 50 MG/ML SYRINGEML. The $12,260.32 contract has a completion date of May 29, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) worth $999,999,999.00 with DLA Troop Support Medical, which serves as a global pharmaceutical support vehicle for military...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $8,400.82 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ENBREL 50 MG/ML SURECLICK medication. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical for a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FFKU7
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corp for the supply of ENBREL 50 MG/ML SYRINGEML. The contract, valued at $8,972.76, has a period of performance through September 5, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which enables the agency to efficiently procure a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 12/4/24, 9:36 AM